{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T18:12:37Z","timestamp":1788286357521,"version":"build-2803163510"},"update-to":[{"DOI":"10.1371\/journal.pgen.1009525","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T00:00:00Z","timestamp":1620086400000}}],"reference-count":79,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T00:00:00Z","timestamp":1619049600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["220530\/Z\/20\/Z"],"award-info":[{"award-number":["220530\/Z\/20\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000883","name":"University of Bristol","doi-asserted-by":"crossref","award":["de Pass VC Research Fellowship"],"award-info":[{"award-number":["de Pass VC Research Fellowship"]}],"id":[{"id":"10.13039\/501100000883","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000361","name":"Diabetes UK","doi-asserted-by":"crossref","award":["SBF004\\1079"],"award-info":[{"award-number":["SBF004\\1079"]}],"id":[{"id":"10.13039\/501100000361","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"crossref","award":["C18281\/A19169"],"award-info":[{"award-number":["C18281\/A19169"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Medical Research Council","award":["MC_UU_00011\/1"],"award-info":[{"award-number":["MC_UU_00011\/1"]}]},{"name":"Medical Research Council","award":["MC_UU_00011\/7"],"award-info":[{"award-number":["MC_UU_00011\/7"]}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"crossref","award":["C68933\/A28534"],"award-info":[{"award-number":["C68933\/A28534"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"crossref","award":["RP-PG-0707-10034"],"award-info":[{"award-number":["RP-PG-0707-10034"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"crossref","award":["RP-PG-0707-10034"],"award-info":[{"award-number":["RP-PG-0707-10034"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"crossref","award":["C18281\/A19169"],"award-info":[{"award-number":["C18281\/A19169"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P50 CA097190"],"award-info":[{"award-number":["P50 CA097190"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 CA047904"],"award-info":[{"award-number":["P30 CA047904"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DE025712"],"award-info":[{"award-number":["R01 DE025712"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","award":["1X01HG007780-0"],"award-info":[{"award-number":["1X01HG007780-0"]}],"id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007316","name":"Division of Cancer Prevention, National Cancer Institute","doi-asserted-by":"publisher","award":["R01-CA90731"],"award-info":[{"award-number":["R01-CA90731"]}],"id":[{"id":"10.13039\/100007316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000361","name":"Diabetes UK","doi-asserted-by":"crossref","award":["17\/0005587"],"award-info":[{"award-number":["17\/0005587"]}],"id":[{"id":"10.13039\/501100000361","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000361","name":"Diabetes UK","doi-asserted-by":"crossref","award":["17\/0005587"],"award-info":[{"award-number":["17\/0005587"]}],"id":[{"id":"10.13039\/501100000361","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000321","name":"World Cancer Research Fund","doi-asserted-by":"crossref","award":["IIG_2019_2009"],"award-info":[{"award-number":["IIG_2019_2009"]}],"id":[{"id":"10.13039\/501100000321","id-type":"DOI","asserted-by":"crossref"}]},{"name":"GENCAPO\/FAPESP","award":["10\/51168-0"],"award-info":[{"award-number":["10\/51168-0"]}]},{"name":"GENCAPO\/FAPESP","award":["10\/51168-0"],"award-info":[{"award-number":["10\/51168-0"]}]}],"content-domain":{"domain":["www.plosgenetics.org"],"crossmark-restriction":false},"short-container-title":["PLoS Genet"],"abstract":"<jats:p>\n                    Head and neck squamous cell carcinoma (HNSCC), which includes cancers of the oral cavity and oropharynx, is a cause of substantial global morbidity and mortality. Strategies to reduce disease burden include discovery of novel therapies and repurposing of existing drugs. Statins are commonly prescribed for lowering circulating cholesterol by inhibiting HMG-CoA reductase (HMGCR). Results from some observational studies suggest that statin use may reduce HNSCC risk. We appraised the relationship of genetically-proxied cholesterol-lowering drug targets and other circulating lipid traits with oral (OC) and oropharyngeal (OPC) cancer risk using two-sample Mendelian randomization (MR). For the primary analysis, germline genetic variants in\n                    <jats:italic>HMGCR<\/jats:italic>\n                    ,\n                    <jats:italic>NPC1L1<\/jats:italic>\n                    ,\n                    <jats:italic>CETP<\/jats:italic>\n                    ,\n                    <jats:italic>PCSK9<\/jats:italic>\n                    and\n                    <jats:italic>LDLR<\/jats:italic>\n                    were used to proxy the effect of low-density lipoprotein cholesterol (LDL-C) lowering therapies. In secondary analyses, variants were used to proxy circulating levels of other lipid traits in a genome-wide association study (GWAS) meta-analysis of 188,578 individuals. Both primary and secondary analyses aimed to estimate the downstream causal effect of cholesterol lowering therapies on OC and OPC risk. The second sample for MR was taken from a GWAS of 6,034 OC and OPC cases and 6,585 controls (GAME-ON). Analyses were replicated in UK Biobank, using 839 OC and OPC cases and 372,016 controls and the results of the GAME-ON and UK Biobank analyses combined in a fixed-effects meta-analysis. We found limited evidence of a causal effect of genetically-proxied LDL-C lowering using HMGCR, NPC1L1, CETP or other circulating lipid traits on either OC or OPC risk. Genetically-proxied PCSK9 inhibition equivalent to a 1 mmol\/L (38.7 mg\/dL) reduction in LDL-C was associated with an increased risk of OC and OPC combined (OR 1.8 95%CI 1.2, 2.8, p = 9.31 x10\n                    <jats:sup>-05<\/jats:sup>\n                    ), with good concordance between GAME-ON and UK Biobank (\n                    <jats:italic>I<\/jats:italic>\n                    <jats:sup>2<\/jats:sup>\n                    = 22%). Effects for PCSK9 appeared stronger in relation to OPC (OR 2.6 95%CI 1.4, 4.9) than OC (OR 1.4 95%CI 0.8, 2.4). LDLR variants, resulting in genetically-proxied reduction in LDL-C equivalent to a 1 mmol\/L (38.7 mg\/dL), reduced the risk of OC and OPC combined (OR 0.7, 95%CI 0.5, 1.0, p = 0.006). A series of pleiotropy-robust and outlier detection methods showed that pleiotropy did not bias our findings. We found limited evidence for a role of cholesterol-lowering in OC and OPC risk, suggesting previous observational results may have been confounded. There was some evidence that genetically-proxied inhibition of PCSK9 increased risk, while lipid-lowering variants in LDLR, reduced risk of combined OC and OPC. This result suggests that the mechanisms of action of PCSK9 on OC and OPC risk may be independent of its cholesterol lowering effects; however, this was not supported uniformly across all sensitivity analyses and further replication of this finding is required.\n                  <\/jats:p>","DOI":"10.1371\/journal.pgen.1009525","type":"journal-article","created":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T16:22:25Z","timestamp":1619108545000},"page":"e1009525","update-policy":"https:\/\/doi.org\/10.1371\/journal.pgen.corrections_policy","source":"Crossref","is-referenced-by-count":31,"title":["Using genetic variants to evaluate the causal effect of cholesterol lowering on head and neck cancer risk: A Mendelian randomization study"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5733-6304","authenticated-orcid":true,"given":"Mark","family":"Gormley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Yarmolinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3756-040X","authenticated-orcid":true,"given":"Tom","family":"Dudding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3208-0389","authenticated-orcid":true,"given":"Kimberley","family":"Burrows","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7992-7719","authenticated-orcid":true,"given":"Richard M.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9256-6065","authenticated-orcid":true,"given":"Jessica","family":"Tyrrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0518-8714","authenticated-orcid":true,"given":"Paul","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miranda","family":"Pring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1864-749X","authenticated-orcid":true,"given":"Stefania","family":"Boccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew F.","family":"Olshan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda","family":"Diergaarde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4486-7496","authenticated-orcid":true,"given":"Rayjean J.","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3897-5861","authenticated-orcid":true,"given":"Danny","family":"Legge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2603-2057","authenticated-orcid":true,"given":"Eloiza H.","family":"Tajara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6682-9343","authenticated-orcid":true,"given":"Patricia","family":"Severino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2868-4822","authenticated-orcid":true,"given":"Martin","family":"Lacko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R.","family":"Ness","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1407-8314","authenticated-orcid":true,"given":"George","family":"Davey Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8917-7384","authenticated-orcid":true,"given":"Emma E.","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0574-5071","authenticated-orcid":true,"given":"Rebecca C.","family":"Richmond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,4,22]]},"reference":[{"issue":"4\u20135","key":"pgen.1009525.ref001","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.oraloncology.2008.06.002","article-title":"Global epidemiology of oral and oropharyngeal cancer","volume":"45","author":"S Warnakulasuriya","year":"2009","journal-title":"Oral Oncol"},{"issue":"1","key":"pgen.1009525.ref002","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000330807","article-title":"Gender and ethnic disparities in incidence and survival of squamous cell carcinoma of the oral tongue, base of tongue, and tonsils: a surveillance, epidemiology and end results program-based analysis","volume":"81","author":"NF Saba","year":"2011","journal-title":"Oncology"},{"key":"pgen.1009525.ref003","author":"Cancer Research UK (CRUK)","year":"2019","journal-title":"Head and neck cancer statistics"},{"issue":"S2","key":"pgen.1009525.ref004","doi-asserted-by":"crossref","first-page":"S181","DOI":"10.1017\/S002221511600061X","article-title":"Recurrent head and neck cancer: United Kingdom National Multidisciplinary Guidelines","volume":"130","author":"H Mehanna","year":"2016","journal-title":"J Laryngol Otol"},{"issue":"3","key":"pgen.1009525.ref005","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0194-5998(99)70287-1","article-title":"Physical and psychosocial correlates of head and neck cancer: a review of the literature","volume":"120","author":"MF De Boer","year":"1999","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"4","key":"pgen.1009525.ref006","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/coa.13144","article-title":"The changing aetiology of head and neck squamous cell cancer: A tale of three cancers?","volume":"43","author":"SJ Thomas","year":"2018","journal-title":"Clin Otolaryngol."},{"issue":"1","key":"pgen.1009525.ref007","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer","volume":"363","author":"KK Ang","year":"2010","journal-title":"N Engl J Med"},{"issue":"5","key":"pgen.1009525.ref008","first-page":"299","article-title":"HPV in oropharyngeal cancer: the basics to know in clinical practice","volume":"34","author":"S Elrefaey","year":"2014","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"pgen.1009525.ref009","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.phrs.2017.07.013","article-title":"Drug repurposing in cancer","volume":"124","author":"L Sleire","year":"2017","journal-title":"Pharmacol Res"},{"issue":"3","key":"pgen.1009525.ref010","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/2042098612439884","article-title":"Safety of statins: an update","volume":"3","author":"M Hu","year":"2012","journal-title":"Ther Adv Drug Saf"},{"issue":"11","key":"pgen.1009525.ref011","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1111\/bcp.13709","article-title":"The \u2018top 100\u2019 drugs and classes in England: an updated \u2018starter formulary\u2019 for trainee prescribers","volume":"84","author":"S Audi","year":"2018","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"5519","key":"pgen.1009525.ref012","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1126\/science.1059344","article-title":"Structural mechanism for statin inhibition of HMG-CoA reductase","volume":"292","author":"ES Istvan","year":"2001","journal-title":"Science"},{"issue":"10","key":"pgen.1009525.ref013","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1001\/jama.2017.11467","article-title":"Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk","volume":"318","author":"BA Ference","year":"2017","journal-title":"JAMA"},{"issue":"19","key":"pgen.1009525.ref014","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1056\/NEJMoa1201735","article-title":"Statin Use and Reduced Cancer-Related Mortality","volume":"367","author":"SF Nielsen","year":"2012","journal-title":"New Engl J Med"},{"issue":"1","key":"pgen.1009525.ref015","doi-asserted-by":"crossref","first-page":"16804","DOI":"10.1038\/s41598-018-35103-1","article-title":"Statin-induced metabolic reprogramming in head and neck cancer: a biomarker for targeting monocarboxylate transporters","volume":"8","author":"M Mehibel","year":"2018","journal-title":"Sci Rep"},{"issue":"1","key":"pgen.1009525.ref016","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4103\/0971-5851.81888","article-title":"The relationship between serum lipid levels and the risk of oral cancer","volume":"32","author":"JG Chawda","year":"2011","journal-title":"Indian J Med Paediatr Oncol"},{"issue":"3","key":"pgen.1009525.ref017","first-page":"345","article-title":"Serum lipid profile in patients with oral cancer and oral precancerous conditions","volume":"11","author":"R Mehta","year":"2014","journal-title":"Dent Res J (Isfahan)"},{"issue":"5","key":"pgen.1009525.ref018","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1002\/hed.25501","article-title":"Inverse association between statin use and head and neck cancer: Population-based case-control study in Han population","volume":"41","author":"LT Kao","year":"2019","journal-title":"Head Neck-J Sci Spec"},{"issue":"10","key":"pgen.1009525.ref019","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1038\/s41591-019-0597-x","article-title":"Avoidable flaws in observational analyses: an application to statins and cancer","volume":"25","author":"BA Dickerman","year":"2019","journal-title":"Nat Med"},{"issue":"1","key":"pgen.1009525.ref020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ije\/dyg070","article-title":"\u2019Mendelian randomization\u2019: can genetic epidemiology contribute to understanding environmental determinants of disease?","volume":"32","author":"GD Smith","year":"2003","journal-title":"Int J Epidemiol."},{"issue":"R1","key":"pgen.1009525.ref021","doi-asserted-by":"crossref","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","article-title":"Mendelian randomization: genetic anchors for causal inference in epidemiological studies","volume":"23","author":"G Davey Smith","year":"2014","journal-title":"Hum Mol Genet"},{"key":"pgen.1009525.ref022","doi-asserted-by":"crossref","first-page":"k601","DOI":"10.1136\/bmj.k601","article-title":"Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians","volume":"362","author":"NM Davies","year":"2018","journal-title":"BMJ"},{"issue":"6","key":"pgen.1009525.ref023","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/ije\/dyx207","article-title":"Mendelian randomization: a novel approach for the prediction of adverse drug events and drug repurposing opportunities","volume":"46","author":"VM Walker","year":"2017","journal-title":"Int J Epidemiol"},{"issue":"7307","key":"pgen.1009525.ref024","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nature09270","article-title":"Biological, clinical and population relevance of 95 loci for blood lipids","volume":"466","author":"TM Teslovich","year":"2010","journal-title":"Nature"},{"issue":"11","key":"pgen.1009525.ref025","doi-asserted-by":"crossref","first-page":"1274-","DOI":"10.1038\/ng.2797","article-title":"Discovery and refinement of loci associated with lipid levels","volume":"45","author":"CJ Willer","year":"2013","journal-title":"Nat Genet"},{"issue":"32","key":"pgen.1009525.ref026","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"38","author":"BA Ference","year":"2017","journal-title":"Eur Heart J"},{"issue":"15","key":"pgen.1009525.ref027","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/j.jacc.2015.02.020","article-title":"Effect of naturally random allocation to lower low-density lipoprotein cholesterol on the risk of coronary heart disease mediated by polymorphisms in NPC1L1, HMGCR, or both: a 2 x 2 factorial Mendelian randomization study","volume":"65","author":"BA Ference","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"pgen.1009525.ref028","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1056\/NEJMoa1604304","article-title":"Variation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and Diabetes","volume":"375","author":"BA Ference","year":"2016","journal-title":"N Engl J Med"},{"key":"pgen.1009525.ref029","first-page":"2020","article-title":"Predicting the effect of statins on cancer risk using genetic variants: a Mendelian randomization study in UK Biobank","volume":"2020","author":"P Carter","journal-title":"medRxiv"},{"issue":"7","key":"pgen.1009525.ref030","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1001\/jama.2020.0150","article-title":"Association Between Genetically Proxied Inhibition of HMG-CoA Reductase and Epithelial Ovarian Cancer","volume":"323","author":"J Yarmolinsky","year":"2020","journal-title":"JAMA"},{"issue":"11","key":"pgen.1009525.ref031","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJMoa1806747","article-title":"Mendelian Randomization Study of ACLY and Cardiovascular Disease","volume":"380","author":"BA Ference","year":"2019","journal-title":"N Engl J Med"},{"key":"pgen.1009525.ref032","doi-asserted-by":"crossref","first-page":"11122","DOI":"10.1038\/ncomms11122","article-title":"Genome-wide study for circulating metabolites identifies 62 loci and reveals novel systemic effects of LPA","volume":"7","author":"J Kettunen","year":"2016","journal-title":"Nat Commun"},{"issue":"12","key":"pgen.1009525.ref033","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1038\/ng.3685","article-title":"Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer","volume":"48","author":"C Lesseur","year":"2016","journal-title":"Nat Genet"},{"issue":"12","key":"pgen.1009525.ref034","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1158\/2159-8290.CD-NB2013-159","article-title":"Consortium launches genotyping effort","volume":"3","author":"O Consortium","year":"2013","journal-title":"Cancer Discov"},{"issue":"5","key":"pgen.1009525.ref035","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1002\/ijc.31377","article-title":"Assessing the causal association between 25-hydroxyvitamin D and the risk of oral and oropharyngeal cancer using Mendelian randomization","volume":"143","author":"T Dudding","year":"2018","journal-title":"Int J Cancer"},{"issue":"5","key":"pgen.1009525.ref036","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/ije\/dyt179","article-title":"Calculating statistical power in Mendelian randomization studies","volume":"42","author":"MJ Brion","year":"2013","journal-title":"Int J Epidemiol"},{"issue":"21","key":"pgen.1009525.ref037","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1093\/bioinformatics\/btv402","article-title":"LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants","volume":"31","author":"MJ Machiela","year":"2015","journal-title":"Bioinformatics"},{"issue":"6","key":"pgen.1009525.ref038","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1093\/ije\/dyx034","article-title":"MendelianRandomization: an R package for performing Mendelian randomization analyses using summarized data","volume":"46","author":"OO Yavorska","year":"2017","journal-title":"Int J Epidemiol"},{"issue":"7","key":"pgen.1009525.ref039","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10654-015-0011-z","article-title":"Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors","volume":"30","author":"S Burgess","year":"2015","journal-title":"Eur J Epidemiol"},{"issue":"11","key":"pgen.1009525.ref040","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1002\/sim.6835","article-title":"Combining information on multiple instrumental variables in Mendelian randomization: comparison of allele score and summarized data methods","volume":"35","author":"S Burgess","year":"2016","journal-title":"Stat Med"},{"issue":"10","key":"pgen.1009525.ref041","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/ng.3396","article-title":"A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease","volume":"47","author":"M Nikpay","year":"2015","journal-title":"Nat Genet"},{"issue":"R2","key":"pgen.1009525.ref042","doi-asserted-by":"crossref","first-page":"R195","DOI":"10.1093\/hmg\/ddy163","article-title":"Evaluating the potential role of pleiotropy in Mendelian randomization studies","volume":"27","author":"G Hemani","year":"2018","journal-title":"Hum Mol Genet"},{"issue":"2","key":"pgen.1009525.ref043","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression","volume":"44","author":"J Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"issue":"4","key":"pgen.1009525.ref044","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/gepi.21965","article-title":"Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator","volume":"40","author":"J Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"issue":"6","key":"pgen.1009525.ref045","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1093\/ije\/dyx102","article-title":"Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption","volume":"46","author":"FP Hartwig","year":"2017","journal-title":"Int J Epidemiol"},{"issue":"6","key":"pgen.1009525.ref046","first-page":"1961","article-title":"Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I-2 statistic","volume":"45","author":"J Bowden","year":"2016","journal-title":"Int J Epidemiol"},{"issue":"4","key":"pgen.1009525.ref047","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1093\/ije\/dyy101","article-title":"Improving the visualization, interpretation and analysis of two-sample summary data Mendelian randomization via the Radial plot and Radial regression","volume":"47","author":"J Bowden","year":"2018","journal-title":"Int J Epidemiol"},{"issue":"8","key":"pgen.1009525.ref048","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1038\/s41588-018-0164-2","article-title":"Publisher Correction: Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases","volume":"50","author":"M Verbanck","year":"2018","journal-title":"Nat Genet"},{"issue":"4","key":"pgen.1009525.ref049","doi-asserted-by":"crossref","first-page":"e1008720","DOI":"10.1371\/journal.pgen.1008720","article-title":"Eliciting priors and relaxing the single causal variant assumption in colocalisation analyses","volume":"16","author":"C Wallace","year":"2020","journal-title":"PLOS Genetics."},{"key":"pgen.1009525.ref050","first-page":"166298","article-title":"Genome-wide genetic data on ~500,000 UK Biobank participants","author":"C Bycroft","year":"2017","journal-title":"bioRxiv"},{"key":"pgen.1009525.ref051","author":"R Mitchell","year":"2019","journal-title":"UK Biobank Genetic Data: MRC-IEU Quality Control, version 2"},{"key":"pgen.1009525.ref052","article-title":"Gaunt, TR MRC IEU UK Biobank GWAS pipeline version 2","author":"R Mitchell","year":"2019"},{"key":"pgen.1009525.ref053","first-page":"40","article-title":"meta: an R package for metaanalysis","volume":"7","author":"G Schwarzer","year":"2007","journal-title":"R News"},{"key":"pgen.1009525.ref054","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in metaanalyses","volume":"327","author":"SG Higgins","year":"2003","journal-title":"BMJ Br Med J"},{"issue":"6","key":"pgen.1009525.ref055","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.ajhg.2018.03.021","article-title":"Estimation of Genetic Correlation via Linkage Disequilibrium Score Regression and Genomic Restricted Maximum Likelihood","volume":"102","author":"G Ni","year":"2018","journal-title":"The American Journal of Human Genetics"},{"key":"pgen.1009525.ref056","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41525-019-0078-7","article-title":"A phenome-wide association study to discover pleiotropic effects of PCSK9, APOB, and LDLR","volume":"4","author":"MS Safarova","year":"2019","journal-title":"NPJ Genom Med"},{"issue":"1","key":"pgen.1009525.ref057","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41574-018-0110-5","article-title":"Inhibiting PCSK9\u2014biology beyond LDL control","volume":"15","author":"RM Stoekenbroek","year":"2018","journal-title":"Nat Rev Endocrinol"},{"issue":"8","key":"pgen.1009525.ref058","doi-asserted-by":"crossref","first-page":"938","DOI":"10.15252\/msb.20177703","article-title":"Network analyses identify liver-specific targets for treating liver diseases","volume":"13","author":"S Lee","year":"2017","journal-title":"Mol Syst Biol"},{"issue":"5\u20136","key":"pgen.1009525.ref059","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/prca.201200069","article-title":"SILAC-based quantitative proteomic analysis of gastric cancer secretome","volume":"7","author":"A Marimuthu","year":"2013","journal-title":"Proteomics Clin Appl"},{"issue":"2","key":"pgen.1009525.ref060","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.atherosclerosis.2014.05.931","article-title":"CETP inhibitors downregulate hepatic LDL receptor and PCSK9 expression in vitro and in vivo through a SREBP2 dependent mechanism","volume":"235","author":"B Dong","year":"2014","journal-title":"Atherosclerosis"},{"key":"pgen.1009525.ref061","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.atherosclerosis.2018.09.033","article-title":"CETP inhibition, statins and diabetes","volume":"278","author":"PJ Barter","year":"2018","journal-title":"Atherosclerosis"},{"key":"pgen.1009525.ref062","author":"THP Atlas","year":"2020","journal-title":"PCKS9"},{"key":"pgen.1009525.ref063","author":"TH Atlas","year":"2020","journal-title":"LDLR Tissue"},{"issue":"1","key":"pgen.1009525.ref064","doi-asserted-by":"crossref","first-page":"17167","DOI":"10.1038\/s41598-019-53603-6","article-title":"PCSK9 inhibition as a novel therapeutic target for alcoholic liver disease","volume":"9","author":"JS Lee","year":"2019","journal-title":"Scientific Reports"},{"issue":"6","key":"pgen.1009525.ref065","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/acer.14039","article-title":"PCSK9 is Increased in Cerebrospinal Fluid of Individuals With Alcohol Use Disorder","volume":"43","author":"JS Lee","year":"2019","journal-title":"Alcoholism: Clinical and Experimental Research"},{"issue":"17","key":"pgen.1009525.ref066","doi-asserted-by":"crossref","first-page":"7399","DOI":"10.1002\/cam4.2500","article-title":"Association of statin use with risk of Gleason score-specific prostate cancer: A hospital-based cohort study","volume":"8","author":"K Wang","year":"2019","journal-title":"Cancer Medicine"},{"issue":"21","key":"pgen.1009525.ref067","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1056\/NEJMoa043792","article-title":"Statins and the risk of colorectal cancer","volume":"352","author":"JN Poynter","year":"2005","journal-title":"N Engl J Med"},{"issue":"5","key":"pgen.1009525.ref068","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1378\/chest.06-0931","article-title":"Statins reduce the risk of lung cancer in humans: a large case-control study of US veterans","volume":"131","author":"V Khurana","year":"2007","journal-title":"Chest"},{"issue":"4","key":"pgen.1009525.ref069","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/aje\/kwi203","article-title":"Statins and prostate cancer risk: a case-control study","volume":"162","author":"J Shannon","year":"2005","journal-title":"Am J Epidemiol"},{"issue":"1","key":"pgen.1009525.ref070","doi-asserted-by":"crossref","first-page":"e29849","DOI":"10.1371\/journal.pone.0029849","article-title":"Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy","volume":"7","author":"C Cholesterol Treatment Trialists","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"pgen.1009525.ref071","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1001\/jama.295.1.74","article-title":"Statins and cancer risk: a meta-analysis","volume":"295","author":"KM Dale","year":"2006","journal-title":"JAMA"},{"key":"pgen.1009525.ref072","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jclinepi.2016.04.014","article-title":"Specifying a target trial prevents immortal time bias and other self-inflicted injuries in observational analyses","volume":"79","author":"MA Hernan","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"pgen.1009525.ref073","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.oraloncology.2018.08.015","article-title":"Protective effects of metformin, statins and anti-inflammatory drugs on head and neck cancer: A systematic review","volume":"85","author":"C Saka Herran","year":"2018","journal-title":"Oral Oncol"},{"issue":"4","key":"pgen.1009525.ref074","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/sj.neo.7900247","article-title":"Microarray and biochemical analysis of lovastatin-induced apoptosis of squamous cell carcinomas","volume":"4","author":"J Dimitroulakos","year":"2002","journal-title":"Neoplasia"},{"issue":"1","key":"pgen.1009525.ref075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2012.04.011","article-title":"Statins and cancer: current and future prospects","volume":"324","author":"M Osmak","year":"2012","journal-title":"Cancer Lett"},{"issue":"3","key":"pgen.1009525.ref076","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1152\/physrev.00030.2014","article-title":"Obesity and Diabetes: The Increased Risk of Cancer and Cancer-Related Mortality","volume":"95","author":"EJ Gallagher","year":"2015","journal-title":"Physiol Rev"},{"issue":"6","key":"pgen.1009525.ref077","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1177\/1479164114550813","article-title":"Diabetes and cancer: Epidemiology and potential mechanisms","volume":"11","author":"HG Joost","year":"2014","journal-title":"Diabetes Vasc Dis Re"},{"issue":"11","key":"pgen.1009525.ref078","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1158\/1940-6207.CAPR-12-0140","article-title":"Obesity, Energy Balance, and Cancer: New Opportunities for Prevention","volume":"5","author":"SD Hursting","year":"2012","journal-title":"Cancer Prev Res"},{"key":"pgen.1009525.ref079","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12876-015-0371-6","article-title":"Decreased PCSK9 expression in human hepatocellular carcinoma","volume":"15","author":"M Bhat","year":"2015","journal-title":"BMC Gastroenterol"}],"updated-by":[{"DOI":"10.1371\/journal.pgen.1009525","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T00:00:00Z","timestamp":1620086400000}}],"container-title":["PLOS Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pgen.1009525","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T11:42:49Z","timestamp":1698925369000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pgen.1009525"}},"subtitle":[],"editor":[{"given":"Thilo","family":"D\u00f6rk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,4,22]]},"references-count":79,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,4,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pgen.1009525","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.10.05.20206268","asserted-by":"object"}]},"ISSN":["1553-7404"],"issn-type":[{"value":"1553-7404","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,22]]}}}